Correlation Between Caribou Biosciences and Prime Medicine,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Prime Medicine, Common, you can compare the effects of market volatilities on Caribou Biosciences and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Prime Medicine,.

Diversification Opportunities for Caribou Biosciences and Prime Medicine,

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Caribou and Prime is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Prime Medicine, go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Prime Medicine,

Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.13 times more return on investment than Prime Medicine,. However, Caribou Biosciences is 1.13 times more volatile than Prime Medicine, Common. It trades about -0.02 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.04 per unit of risk. If you would invest  533.00  in Caribou Biosciences on November 1, 2024 and sell it today you would lose (402.00) from holding Caribou Biosciences or give up 75.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Caribou Biosciences  vs.  Prime Medicine, Common

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Prime Medicine, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.

Caribou Biosciences and Prime Medicine, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and Prime Medicine,

The main advantage of trading using opposite Caribou Biosciences and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.
The idea behind Caribou Biosciences and Prime Medicine, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals